Finance

Lists
BFK:SGX
Pharmesis International Ltd.
SGD 0,095
0,00%
(0,00) 1D
30 Sep., 15:20:31 GMT+8  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for BFK...
Mkt. cap
3,01 m
Avg. vol.
133,00
Volume
0,00
52-wk high
SGD 0,45
52-wk low
SGD 0,08
EPS
-SGD 0,04
Shares outstanding
31,70 m
Mkt. cap
3,01 m
Avg. vol.
133,00
Volume
0,00
52-wk high
SGD 0,45
52-wk low
SGD 0,08
EPS
-SGD 0,04
Shares outstanding
31,70 m
News stories
From web sources and news partners
About Pharmesis International Ltd.
CEO-
Employees-
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitepharmesis.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
8,28 m
8,28 m
5,93 m
5,93 m
Cost of goods sold
5,53 m
5,53 m
3,92 m
3,92 m
Cost of revenue
5,53 m
5,53 m
3,92 m
3,92 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,83 m
4,83 m
4,63 m
4,63 m
Operating expense
4,88 m
4,88 m
4,05 m
4,05 m
Total operating expenses
10,41 m
10,41 m
7,97 m
7,97 m
Operating income
-2,13 m
-2,13 m
-2,03 m
-2,03 m
Other non operating income
982,50 k
982,50 k
500,00
500,00
EBT including unusual items
-1,31 m
-1,31 m
-2,18 m
-2,18 m
EBT excluding unusual items
-1,31 m
-1,31 m
-2,18 m
-2,18 m
Income tax expense
153,00 k
153,00 k
-
-
Effective tax rate
-11,67%
-11,67%
-
-
Other operating expenses
52,00 k
52,00 k
-583,50 k
-583,50 k
Net income
-1,46 m
-1,46 m
-2,18 m
-2,18 m
Net profit margin
-17,70%
-17,70%
-36,75%
-36,75%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-159,50 k
-159,50 k
-147,50 k
-147,50 k
Net interest expenses
-159,50 k
-159,50 k
-147,50 k
-147,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,71 m
-1,71 m
-1,31 m
-1,31 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme